Psilocybin in the News
The latest news about psilocybin for addiction, depression and anxiety
New research published in the Journal of Psychopharmacology has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 months after the acute psychedelic treatment.
Source: New Atlas
Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the active ingredient in hallucinogenic mushrooms.
Psychedelic treatments for addiction challenge 12-step’s ideas about what sobriety is: total abstinence from any mood- or mind-altering drug—psychedelics included.
Source: Vice News
Single dose of psilocybin leads to decreased demoralisation and improved spiritual wellbeing among cancer sufferers, long-term research indicates.
Source: The Independent
Johns Hopkins researchers report that a small number of longtime smokers who had failed many attempts to drop the habit did so after a carefully controlled and monitored use of psilocybin, the active hallucinogenic agent in so-called “magic mushrooms,” in the context of a cognitive behavioral therapy treatment program.
Source: Johns Hopkins
Two studies published Thursday in the Journal of Psychopharmacology suggest that psilocybin may offer a dramatic helping hand.
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy, appears to be associated with significant improvements in emotional and existential distress in people with cancer
Source: NYU Langone
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look. Scientists are rediscovering what many see as the substances’ astonishing therapeutic potential for a vast range of issues, from depression to drug addiction and acceptance of mortality.
Source: Scientific American
Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested.
In a new study, Yale researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in the journal Neuron.
Source: Yale News